[Complications due to malnutrition and intrauterine growth restriction in preterm newborns]

Mayra Patricia Arteaga-Mancera1, Mario Enrique Rendón-Macías, José Iglesias-Leboreiro

  • 1Facultad Mexicana de Medicina, Universidad La Salle, Distrito Federal, México. mario.rendon@imss.gob.mx.

Insights

Preterm infants diagnosed with intrauterine growth restriction (IUGR) and malnutrition at birth face increased neonatal complications. Early identification and management of these conditions are crucial for improving infant outcomes.

Area of Science:

  • Neonatology
  • Perinatal Medicine
  • Pediatric Nutrition

Context:

  • Preterm infants are at higher risk for neonatal complications.
  • Intrauterine growth restriction (IUGR) and malnutrition are significant concerns in high-risk pregnancies.
  • Understanding the combined impact of IUGR and malnutrition on preterm neonates is critical for clinical practice.

Purpose:

  • To investigate the association between intrauterine growth restriction (IUGR) and/or malnutrition at birth and the incidence of neonatal complications in preterm infants.
  • To compare neonatal outcomes across different categories of preterm infants based on IUGR and nutritional status at birth.

Summary:

  • This study analyzed four cohorts of preterm infants, categorizing them by the presence or absence of IUGR and malnutrition at birth.
  • Neonatal morbidities and hospital stay were assessed. Results indicated that infants with IUGR, particularly those also malnourished, experienced more complications.
  • While IUGR infants had longer hospital stays, nutritional status did not significantly alter this duration.

Impact:

  • The findings highlight that significant growth impairments, specifically malnutrition in preterm infants diagnosed with IUGR, elevate the risk of neonatal complications.
  • This underscores the importance of nutritional assessment and intervention in preterm infants with IUGR.
  • Improved understanding can guide targeted clinical management strategies to mitigate adverse neonatal outcomes.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
2.0K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
35
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K